메뉴 건너뛰기




Volumn 98, Issue 5, 2008, Pages 393-396

A safe and fast technique for isolated hepatic perfusion

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CANNULATION; CLINICAL ARTICLE; COST MINIMIZATION ANALYSIS; FEMALE; GASTRODUODENAL ARTERY; HUMAN; LAPAROTOMY; LIVER METASTASIS; LIVER PERFUSION; MALE; OPERATION DURATION; PRIORITY JOURNAL; SAFETY; SHUNTING; SURGICAL TECHNIQUE; TREATMENT INDICATION;

EID: 53549096524     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.21113     Document Type: Article
Times cited : (4)

References (7)
  • 1
    • 9144253461 scopus 로고    scopus 로고
    • The past decade of experience with isolated hepatic perfusion
    • Grover A, Alexander HR: The past decade of experience with isolated hepatic perfusion. The Oncologist 2004;9:653-664.
    • (2004) The Oncologist , vol.9 , pp. 653-664
    • Grover, A.1    Alexander, H.R.2
  • 2
    • 53549127912 scopus 로고    scopus 로고
    • Phase I Trial Results for Liver Perfusion with Oxaliplatin
    • Puerto Rico, February 24-27
    • Zeh H: Phase I Trial Results for Liver Perfusion with Oxaliplatin. Second International Symposium on regional Cancer Therapies. Puerto Rico, February 24-27, 2007.
    • (2007) Second International Symposium on regional Cancer Therapies
    • Zeh, H.1
  • 3
    • 0035137038 scopus 로고    scopus 로고
    • Isolated hepatic perfusion for unresectable hepatic metastases from colorectal cancer
    • Bartlett DL, Libutti SK, Figg WD, et al.: Isolated hepatic perfusion for unresectable hepatic metastases from colorectal cancer. Surgery 2001;129:176-187.
    • (2001) Surgery , vol.129 , pp. 176-187
    • Bartlett, D.L.1    Libutti, S.K.2    Figg, W.D.3
  • 4
    • 0346333288 scopus 로고    scopus 로고
    • Hyperthermic isolated hepatic perfusion using melphalan for patients with ocular melanoma metastatic to the liver
    • Alexander HR, Libutti SK, Pingpank JF, et al.: Hyperthermic isolated hepatic perfusion using melphalan for patients with ocular melanoma metastatic to the liver. Clin Cancer Res 2003;9: 6343-6349.
    • (2003) Clin Cancer Res , vol.9 , pp. 6343-6349
    • Alexander, H.R.1    Libutti, S.K.2    Pingpank, J.F.3
  • 5
    • 10644270999 scopus 로고    scopus 로고
    • Isolated hepatic perfusion for the treatment of patients with advanced liver metastases from pancreatic and gastrointestinal neuroendocrine neoplasms
    • Grover Ac, Libutti Sk, Pingpank JF, et al.: Isolated hepatic perfusion for the treatment of patients with advanced liver metastases from pancreatic and gastrointestinal neuroendocrine neoplasms. Surgery 2004;136:1176-1182.
    • (2004) Surgery , vol.136 , pp. 1176-1182
    • Grover, A.1    Libutti, S.2    Pingpank, J.F.3
  • 6
    • 1242276303 scopus 로고    scopus 로고
    • Treatment of patients with unresectable primary hepatic malignancies using hyperthermic isolated hepatic perfusion
    • Feldman ED, Wu PC, Beresneva T, et al.: Treatment of patients with unresectable primary hepatic malignancies using hyperthermic isolated hepatic perfusion. J Gastrointest Surg 2004;8:200-207.
    • (2004) J Gastrointest Surg , vol.8 , pp. 200-207
    • Feldman, E.D.1    Wu, P.C.2    Beresneva, T.3
  • 7
    • 0033735111 scopus 로고    scopus 로고
    • Technique and results of hyperthermic isolated hepatic perfusion with tumor necrosis factor and melphalan for the treatment of unresectable hepatic malignancies
    • Libutti SK, Bartlett DL, Fraker DL, et al.: Technique and results of hyperthermic isolated hepatic perfusion with tumor necrosis factor and melphalan for the treatment of unresectable hepatic malignancies. J Am Coll Surg 2000;191:519-530.
    • (2000) J Am Coll Surg , vol.191 , pp. 519-530
    • Libutti, S.K.1    Bartlett, D.L.2    Fraker, D.L.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.